Common Contracts
3 similar Registration Rights Agreement contracts by Amgen Inc
REGISTRATION RIGHTS AGREEMENT among AMGEN INC. and BOFA SECURITIES, INC. and each as a Lead Dealer Manager and BNP PARIBAS SECURITIES CORP. DEUTSCHE BANK SECURITIES INC. RBC CAPITAL MARKETS, LLC BLAYLOCK VAN, LLC and SIEBERT WILLIAMS SHANK & CO., LLC...Registration Rights Agreement • August 18th, 2020 • Amgen Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”), is made and entered into this 17th day of August, 2020, among Amgen Inc., a Delaware corporation (the “Company”), and BofA Securities, Inc. and J.P. Morgan Securities LLC (collectively, the “Lead Dealer Managers”), and BNP Paribas Securities Corp., Deutsche Bank Securities Inc., RBC Capital Markets, LLC, Blaylock Van, LLC and Siebert Williams Shank & Co., LLC (collectively, the “Co-Dealer Managers” and, together with the Lead Dealer Managers, the “Dealer Managers”).
REGISTRATION RIGHTS AGREEMENT among AMGEN INC. and CREDIT SUISSE SECURITIES (USA) LLC CITIGROUP GLOBAL MARKETS INC. and MIZUHO SECURITIES USA INC. each as a Lead Dealer Manager and DREXEL HAMILTON, LLC and THE WILLIAMS CAPITAL GROUP, L.P. each as a...Registration Rights Agreement • June 14th, 2016 • Amgen Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”), is made and entered into this 14th day of June, 2016, among Amgen Inc., a Delaware corporation (the “Company”), and Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and Mizuho Securities USA Inc. (the “Lead Dealer Managers”), and Drexel Hamilton, LLC and The Williams Capital Group, L.P. (the “Co-Dealer Managers” and, together with the Lead Dealer Managers, the “Dealer Managers”).
REGISTRATION RIGHTS AGREEMENT between AMGEN INC. and MORGAN STANLEY & CO. INCORPORATED and MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATEDRegistration Rights Agreement • May 30th, 2007 • Amgen Inc • Biological products, (no disgnostic substances) • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into this 30th day of May, 2007, among AMGEN INC., a Delaware corporation (the “Company”), and MORGAN STANLEY & CO. INCORPORATED (“Morgan Stanley”) and MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED (“Merrill Lynch”), acting on behalf of the several parties named in Schedule I (the “Initial Purchasers”) to the Purchase Agreement (as defined below).
